Skip to main content
Livermore
Livermore
ZHEN

Samalin Investment Counsel, LLC

SEC CIK
0001544366
Latest filing
Jul 27, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Samalin Investment Counsel, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q2 2021
Holdings of REGN by Samalin Investment Counsel, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−511−100.0%Sold outHolders
Q1 2026511$394.9K0.1%−10−1.9%ReducedHolders
Q4 2025521$402.1K0.1%−15−2.8%ReducedHolders
Q3 2025536$301.3K0.1%+13+2.5%AddedHolders
Q2 2025523$274.9K0.1%−350−40.1%ReducedHolders
Q1 2025873$553.9K0.2%+117+15.5%AddedHolders
Q4 2024756$538.5K0.2%−35−4.4%ReducedHolders
Q3 2024791$831.5K0.4%+103+15.0%AddedHolders
Q2 2024688$723.1K0.3%+5+0.7%AddedHolders
Q1 2024683$657.4K0.3%−22−3.1%ReducedHolders
Q4 2023705$619.2K0.3%−5−0.7%ReducedHolders
Q3 2023710$584.3K0.3%−8−1.1%ReducedHolders
Q2 2023718$515.9K0.3%−40−5.3%ReducedHolders
Q1 2023758$622.8K0.4%−4−0.5%ReducedHolders
Q4 2022762$549.8K0.3%−53−6.5%ReducedHolders
Q3 2022815$561.0K0.4%+43+5.6%AddedHolders
Q2 2022772$456.0K0.3%−187−19.5%ReducedHolders
Q1 2022959$670.0K0.4%00.0%UnchangedHolders
Q4 2021959$606.0K0.4%00.0%UnchangedHolders
Q3 2021959$580.0K0.4%+44+4.8%AddedHolders
Q2 2021915$511.0K0.3%+915NewHolders